Cancer patients increasingly absorb the financial risk of surviving disease in America. A brain cancer survivor examines how healthcare incentives, insurance design, and policy decisions shifted instability onto patients and families while institutions protect margins.

A conference on patient advocacy with zero patients on the panel says everything. The industry keeps explaining itself while excluding the people who live the consequences. Here is what that looks like and why it keeps happening.

23,000 people follow me on LinkedIn. They are patients, caregivers, and clinicians dealing with insurance denials, medical debt, and delays in care. Here is what they are seeing every day and why it reflects a much larger problem across US healthcare.

The next national election will be shaped by a reality pollsters struggle to explain: one insurance letter or specialist bill can wipe out a family. What if Mark Cuban ran for president on healthcare, and only healthcare, treating it as the defining economic issue of American life?

24 million Americans watched premiums double overnight. Now Trump plans to pressure insurers who banked $543 billion in profits over a decade. The solution? HSAs—which create new revenue streams for the same industry while shifting costs onto patients who already can't afford care. This isn't reform.